Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 7 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 4 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks· 5 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 4 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor ...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 3 days agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 3 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 2 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 3 days agoThe big drugmaker's forward dividend yield stands at nearly 2.4%. The stock is on a roll so far in...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 2 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...